News

MRM Health enters into its first industry collaboration with DuPont Nutrition & Biosciences and boosts its development with an investment of more than €14 million to redefine microbiome-based therapeutics

Ghent, Belgium

Microbiome specialist MRM Health enters into its first industry collaboration with DuPont Nutrition & Biosciences in the field of metabolic diseases. Furthermore, MRM Health has raised more than €14 million to advance its in-house clinical and preclinical development programs in the field of microbiome-based therapeutics and strengthens its partnership with the Flemish Institute of Biotechnology (VIB), KU Leuven and Ghent University.

Press Release

MRM Health appoints Dr. Werner Cautreels as Chairman and Dr. Nigel Horscroft as Chief Scientific Officer

Ghent, Belgium

Microbiome specialist MRM Health is pleased to announce the appointment of its Chairman of the Board and its Chief Scientific Officer.

MRM Health NV, a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome, announced today that Dr. Werner Cautreels, former CEO of Solvay Pharmaceuticals and Selecta Biosciences, has been appointed as Chairman of the Board and Dr. Nigel Horscroft, ex-Curevac and Pfizer, as Chief Scientific Officer. In addition, Dr. Ludo Haazen is joining the R&D organization to support clinical development and medical affairs.

Press Release